Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2014-07-21
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Determinants of Migraine Among Headache Patients
NCT07038499
Migraine and Infertility
NCT03831659
Oxygenation and Perfusion in Patients With Acute Migraine Attacks
NCT03536936
HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs
NCT06155123
Migraine in Adolescents
NCT05654012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with menstrual migraine
Womens presenting with regular menstrual migraine treated with triptans will be included in the study.
Intracranial pressure variations
Self-measure of ICP will be performed outside and during menstrual migraine attacks.
Matched control
The potential variations will be compared to the measures done on matched healthy women outside and during menses.
Intracranial pressure variations
Self-measure of ICP will be performed outside and during menstrual migraine attacks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intracranial pressure variations
Self-measure of ICP will be performed outside and during menstrual migraine attacks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Menstrual migraine
* Using a triptan as usual treatment to relieve attacks
* Usual triptan efficacy although recurrence is possible
Exclusion Criteria
* Intracranial hypertension
* Chronic daily headache
* Use of topiramate or acetazolamide
* Triptans used more than 10 days/month
* Analgesic drug used more than 15 days/month
* Uncontrolled high blood pressure
* BMI \>30
* Ongoing allergic rhinitis or flu
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Clermont-Ferrand
Clermont-Ferrand, Auvergne, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A00042-45
Identifier Type: OTHER
Identifier Source: secondary_id
CHU-331
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.